Nutex Health (NASDAQ:NUTX) Sets New 12-Month High – Time to Buy?

Nutex Health Inc. (NASDAQ:NUTX) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $193.07 and last traded at $189.8350, with a volume of 124524 shares traded. The stock had previously closed at $183.88.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on NUTX. Wall Street Zen raised shares of Nutex Health from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 28th. Weiss Ratings reissued a “hold (c)” rating on shares of Nutex Health in a research report on Monday, December 22nd. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $252.50.

Nutex Health Stock Up 2.6%

The company’s 50-day moving average is $139.71 and its 200 day moving average is $115.14. The stock has a market capitalization of $1.33 billion, a PE ratio of 10.16 and a beta of -0.03. The company has a current ratio of 3.20, a quick ratio of 3.18 and a debt-to-equity ratio of 0.67.

Nutex Health (NASDAQ:NUTX) last released its earnings results on Tuesday, November 18th. The company reported $7.76 earnings per share (EPS) for the quarter, beating the consensus estimate of ($5.43) by $13.19. The firm had revenue of $243.99 million for the quarter, compared to the consensus estimate of $221.93 million. Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.

Insider Activity

In other Nutex Health news, CFO Jon Christian Bates purchased 750 shares of the stock in a transaction on Tuesday, November 25th. The shares were bought at an average cost of $136.71 per share, with a total value of $102,532.50. Following the completion of the acquisition, the chief financial officer owned 5,638 shares in the company, valued at $770,770.98. This trade represents a 15.34% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. 36.92% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in NUTX. Divisadero Street Capital Management LP purchased a new stake in shares of Nutex Health during the 2nd quarter worth $7,481,000. Austin Asset Management Co Inc purchased a new position in Nutex Health in the second quarter valued at about $315,000. Geode Capital Management LLC boosted its stake in shares of Nutex Health by 116.8% during the 2nd quarter. Geode Capital Management LLC now owns 78,859 shares of the company’s stock worth $9,819,000 after acquiring an additional 42,484 shares in the last quarter. Allianz Asset Management GmbH acquired a new stake in shares of Nutex Health in the 2nd quarter worth approximately $314,000. Finally, American Century Companies Inc. increased its stake in Nutex Health by 39.9% in the 2nd quarter. American Century Companies Inc. now owns 104,063 shares of the company’s stock valued at $12,955,000 after purchasing an additional 29,704 shares in the last quarter. Hedge funds and other institutional investors own 5.32% of the company’s stock.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.